Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy

This publication has 75 references indexed in Scilit:

• Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels
  Pain, 2012
• Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
  Nature Neuroscience, 2011
• Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
  Pharmacology Biochemistry and Behavior, 2011
• Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
  Neuropsychopharmacology, 2011
• CXCR4 signaling mediates morphine-induced tactile hyperalgesia
  Brain, Behavior, and Immunity, 2011
• Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
  Neurotherapeutics, 2009
• Inhibitory activity of the novel CB₂receptor agonist, GW833972A, on guinea‐pig and human sensory nerve function in the airways
  British Journal of Pharmacology, 2008
• Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
  Neuropsychopharmacology, 2008
• Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy
  Pain, 2007
• CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy
  Brain, Behavior, and Immunity, 2007